• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE SG; IMPLANTABLE LEAD Back to Search Results
Model Number 0171
Medical Device Problem Code High impedance (1291)
Health Effect - Clinical Code Calcium Deposits/Calcification (1758)
Date of Event 12/30/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that this right ventricular (rv) lead exhibited a gradual increase in shock impedances.A revision procedure was performed.During the procedure, the physician noted the rv lead had calcified.The rv lead was explanted and replaced with a new lead successfully.No additional adverse patient effects were reported.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead exhibited a gradual increase in shock impedances.A revision procedure was performed.During the procedure, the physician noted the rv lead had calcified.The rv lead was explanted and replaced with a new lead successfully.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
This product was explanted and was not returned.As such, physical analysis has not been conducted in our laboratory.Based on the thorough review of available information, and in the absence of a product return, the analysis of available information did not identify a specific complaint cause.Boston scientific has assigned an investigation conclusion code of cause not established.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided a review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE SG
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key24189276
Report Number2124215-2026-04646
Device Sequence Number8065562
Product Code LWS
UDI-Device Identifier00802526373374
UDI-Public(01)00802526373374(17)201217
Combination Product (Y/N)Y
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
P910073
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/15/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date12/17/2020
Device Model Number0171
Device Catalogue Number0171
Device Lot Number104593
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/30/2025
Supplement Date Received by Manufacturer03/31/2026
Initial Report FDA Received Date01/27/2026
Supplement Report FDA Received Date04/15/2026
Date Device Manufactured12/17/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age63 YR
Patient SexMale
-
-